Published: May 07, 2021
-Xenter’s Expanding Team of Industry Leaders Poised to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health-
SALT LAKE CITY (BUSINESS WIRE) Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of four additional industry leaders to its Board of Directors and the closing of a $12M Series A offering of preferred stock. The additional members are
Robert S. Langer, an Institute Professor at MIT and the most cited engineer in history and 4th most cited individual in any field who has authored more than 1,500 scientific papers. He is also a co-founder and board member of Moderna.
USF professor who harnessed the power of cactuses is a top Florida inventor tampabay.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tampabay.com Daily Mail and Mail on Sunday newspapers.
Honoring a Pioneer in Tissue Engineering: Gordana Vunjak-Novakovic Named European Inventor Award 2021 Finalist
Share Article
European Patent Office announces that Columbia University Professor Gordana Vunjak-Novakovic is nominated for her lifelong work in biomedical engineering
Her scientific innovation, entrepreneurial mindset and patented inventions offer the prospect of safer rehabilitative medicine in musculoskeletal, heart and lung conditions, welcoming a new era in regenerative medicine. MUNICH (PRWEB) May 04, 2021 The European Patent Office (EPO) announces that Serbian-American scientist Gordana Vunjak-Novakovic has been nominated as a finalist of the European Inventor Award 2021 for her innovative contribution to biomedical engineering. She has dedicated her decades-long career to developing an ex vivo tissue engineering technique which offers a safer, more precise way of cultivating skeletal, heart, lun
MUNICH (PRWEB) May 04, 2021 The European Patent Office (EPO) announces that Serbian-American scientist Gordana Vunjak-Novakovic has been nominated as a finalist of the European Inventor Award 2021 for her innovative contribution to biomedical engineering. She has dedicated her decades-long career to developing an ex vivo tissue engineering technique which offers a safer, more precise way of cultivating skeletal, heart, lung, and vascular tissue for either transplantation, disease modelling, or drug testing.
Named as one of three finalists in the prestigious “Lifetime achievement” category, Vunjak-Novakovic’s work has solved the intricate problems involved in replacing damaged tissue. Before she developed her technique, tissue replacement either involved a painful graft from a patient’s body or carried the risk of immune rejection in the case of grafts taken from a cadaver. Vunjak-Novakovic’s pioneering te
Explore vital drug delivery innovations at online event
(Anton Salnikov/iStock via Getty Images Plus) On May 5, a panel of experienced industry experts will discuss recent developments during Innovations in Drug Delivery, a free one-hour industry webinar.
The readers of Outsourcing-Pharma are keenly interested in the latest drug delivery developments it’s one of the topics visitors to our website most often search for. Industry professionals know they must keep apprised of the latest discoveries, enhancements to current methods, dosage issues, bioavailability concerns, and other vital matters.
To satisfy their curiosity (and to help them remain competitive in today’s dynamic market), OSP and its sister publication BioPharma-Reporter are presenting a free online event Innovations in Drug Delivery, this Wednesday at 10 am CST. Our editors will be welcoming four leading experts, each bringing a wealth of knowledge and record of innovation, to share